Plus Therapeutics, Inc.
PSTV
$5.50
-$0.03-0.54%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
6/8/2026
-
The Cerbat Gem
6/5/2026
-
TipRanks
6/4/2026
-
Proactive Investors - UK
6/4/2026
-
Globe Newswire
5/26/2026
-
Globe Newswire
5/21/2026
-
The Cerbat Gem
5/19/2026
-
TipRanks Financial Blog
5/19/2026
-
Globe Newswire
5/17/2026
-
The Cerbat Gem
5/15/2026
-
TipRanks Financial Blog
5/15/2026
-
Zacks Investment Research
5/15/2026
-
Zacks Investment Research
5/15/2026
-
Globe Newswire
5/14/2026
-
24/7 Wall St.
5/14/2026
-
TipRanks Financial Blog
5/11/2026
-
Zacks Investment Research
5/11/2026
-
Zacks Investment Research
5/8/2026
-
Globe Newswire
5/8/2026
-
Zacks Investment Research
5/8/2026
-
Zacks Investment Research
5/7/2026
-
Globe Newswire
4/23/2026
-
Globe Newswire
4/22/2026
-
Globe Newswire
4/21/2026
-
Seeking Alpha - Healthcare
4/21/2026
-
Globe Newswire
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Friday, May 15, 2026
Period Date
Tuesday, March 31, 2026
Next Filing
Week of Aug 10 and 14 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
737 255 7194
Address
6420 LEVIT GREEN BOULEVARD
Houston, TX 77021
Houston, TX 77021
Country
Year Founded
Business Description
Sector
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. The company’s lead...
more